Adaptive Biotechnologies

Adaptive Biotechnologies empowers revolutionary insights into the adaptive immune system that will change the course of medicine. Adaptive is at the forefront of immune-based discoveries, combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. We bring the accuracy and sensitivity of our immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. Adaptive is committed to transforming the diagnosis and treatment of immune-mediated diseases including cancer, autoimmune disorders, and infectious disease through ground-breaking immunosequencing applications.